Trial Profile
An Open-Label, Multiple-Dose Extension Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuroma; Pain
- Focus Adverse reactions
- Sponsors Centrexion Therapeutics
- 17 Apr 2017 Status changed from active, no longer recruiting to completed.
- 15 Feb 2016 New trial record